
Overview
Dr. New is the director of the Sickle Cell Disease Program in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. She joined the hospital staff in 2023. She was previously a hematologist-oncologist at Children’s Healthcare of Atlanta, where she most recently served as director of Diversity, Equity and Inclusion and clinical director of the Egleston Sickle Cell Program in the Aflac Cancer and Blood Disorders Center. Before that she was the Egleston hospital’s section chief of hematology-oncology and clinical director in the Aflac Cancer and Blood Disorders Center in Egleston. She was also associate professor of pediatrics at Emory Pediatric Institute. Dr. New has published numerous peer-reviewed articles and book chapters and has given many talks internationally, nationally and regionally. Her research interests include recruitment for multi-center trials in sickle cell, as well as global initiatives in sickle cell disease service, education and awareness. Dr. New earned her medical degree from Mount Sinai School of Medicine in New York. She completed her pediatric internship and residency at University of Medicine and Dentistry of New Jersey-Robert Wood Johnson University Hospital in New Brunswick, New Jersey. She then completed a fellowship in pediatric hematology-oncology at Columbia University/New York Presbyterian Medical Center.
Dr. New is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.
Dr. New is board certified in American Board Of Pediatrics. She is actively involved in clinical research, co-authoring 13 peer reviewed articles. Dr. New is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- EPO
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
Locations
601 5th Street South, Suite 320, Suite 320, Saint Petersburg, FL 33701
3310 Lakeland Hills Boulevard, Lakeland, FL 33805
12220 Bruce B Downs Boulevard, Tampa, FL 33612
Additional Areas of Focus
Dr. New has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins All Children's Outpatient Care, St. Petersburg
Dr. Metts specializes in pediatric hematology/oncology in the Johns Hopkins All Children's Cancer & Blood Disorders Institute. He sees patients on our main campus in St. Petersburg and at the Johns Hopkins All Children’s Outpatient Care Center in Tampa. He joined the hospital in 2016. He received his medical degree from the University of South Carolina School of Medicine and completed an internship and residency in pediatrics at Johns Hopkins All Children’s Hospital through the University of South Florida Morsani School of Medicine. Dr. Metts then trained at Emory University School of Medicine as a pediatric hematology/oncology fellow. His clinical interests include sarcomas, rare solid tumors, and Phase 1 and Phase 2 trials for pediatric solid tumors. Dr. Metts is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Osteosarcoma, Rhabdomyosarcoma, Ewing Sarcoma, and Adult Soft Tissue Sarcoma. Dr. Metts is board certified in American Board Of Pediatrics. Dr. Metts is currently accepting new patients.
Johns Hopkins All Children's Hospital
Dr. Josephson is the director of the Johns Hopkins All Children’s Cancer & Blood Disorders Institute in St. Petersburg, Florida. She is also a professor in Oncology and Pediatrics in the Johns Hopkins University School of Medicine. She joined the medical staff in 2022. She was installed as the Hawkins Family Endowed Chair in the Cancer and Blood Disorders Institute in 2024. Dr. Josephson, who specializes in blood banking/transfusion medicine and hematology-oncology, is recognized internationally as a leader in pediatric transfusion medicine and has made significant contributions to medical education, clinical knowledge, clinical/translational research and patient care. Most recently, she worked as a Professor of Pathology/Laboratory Medicine and Pediatrics and was the director of Clinical Research and associate director of the Emory Center for Transfusion and Cellular Therapies at the Emory University School of Medicine and at Children’s Healthcare of Atlanta. She has authored more than 200 peer-reviewed publications and received multiple NIH-funded and Centers for Disease Control grant awards. Her research is focused on transfusion medicine issues related to pediatric hematology and hemostasis, with a focus on sickle cell disease, neonatology, coagulation in pediatric trauma, and platelet transfusion in various disease states. In 2019, the NIH’s National Heart, Lung and Blood Institute (NHLBI) honored Dr. Josephson’s work as one of its Celebrated Women Scientists. They highlighted some of her important research findings, including that anemia — and not transfusions — is associated with increased risk for necrotizing enterocolitis in neonatal intensive care patients, and her work to decrease complications from red blood cell and platelet transfusions by elucidating how these complications arise in infants and children. Dr. Josephson earned her medical degree from the University of South Florida Morsani College of Medicine. She completed a pediatric residency at the University of Colorado and Children’s Hospital Colorado, followed by clinical fellowships in pediatric hematology/oncology and blood bank/transfusion medicine at Emory University School of Medicine. Dr. Josephson is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Hemolytic Transfusion Reaction, Anemia, Sickle Cell Disease, Hemoglobinopathy, and Splenectomy. Dr. Josephson is board certified in American Board Of Pathology and American Board Of Pediatrics. Dr. Josephson is currently accepting new patients.
Johns Hopkins All Children's Outpatient Care, St. Petersburg
Neil Goldenberg is a Pediatric Hematologist Oncology provider practicing medicine in Saint Petersburg, Florida. Dr. Goldenberg is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Blood Clots, Thrombectomy, and Gastrostomy. Dr. Goldenberg is board certified in American Board Of Pediatrics. Dr. Goldenberg is currently accepting new patients.
Frequently Asked Questions about Dr. Tamara N. New
How do I make an appointment with Dr. Tamara N. New?
You can book an appointment with Dr. Tamara N. New by calling their office at 727-767-4176. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Tamara N. New a top-rated expert for Sickle Cell Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Tamara N. New is classified as an Advanced expert for Sickle Cell Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Tamara N. New specialize in?
While Dr. Tamara N. New is a Pediatric Hematology Oncology, they have specific expertise in Sickle Cell Disease, Hemoglobinopathy, and Congenital Hemolytic Anemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Hematology Oncology.
Does Dr. Tamara N. New participate in research or clinical trials?
Yes. Dr. Tamara N. New has published 13 articles and abstracts on conditions like Sickle Cell Disease. You can view a list of Dr. Tamara N. New's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Tamara N. New accept my insurance?
Dr. Tamara N. New accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 727-767-4176 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AnemiaDr. New isAdvanced. Learn about Anemia.
- Congenital Hemolytic AnemiaDr. New isAdvanced. Learn about Congenital Hemolytic Anemia.
- HemoglobinopathyDr. New isAdvanced. Learn about Hemoglobinopathy.
- Hemolytic AnemiaDr. New isAdvanced. Learn about Hemolytic Anemia.
- Sickle Cell DiseaseDr. New isAdvanced. Learn about Sickle Cell Disease.


